Navigation Links
Concord Medical Reports Second Quarter 2013 Financial Results
Date:8/12/2013

plus interest, taxes, depreciation and amortization, share-based compensation expenses and other adjustments. Other adjustments include foreign exchange gain, gain(loss) from disposal of property, plant and equipment and other income or expense. 

 

 

Concord Medical Services Holdings Co., Ltd. Consolidated Balance Sheets(in thousands)December 31, 2012June 30, 2013RMB

RMB

US$(Unaudited)

(Unaudited)ASSETSCurrent assetsCash

75,382

215,034

35,037Restricted cash, current portion

284,047

279,105

45,476Accounts receivable

210,307

247,391

40,309Inventories

8,681

14,484

2,360Prepayments and other current assets

67,472

119,541

19,477Net investments in direct financing leases, current portion

89,451

119,255

19,431Deferred tax assets, current portion

16,593

23,927

3,899Loan to a noncontrolling shareholder of a subsidiary

100,000

93,410

15,220Amount due from related parties

1,200

1,973

321Total current assets853,1331,114,120181,530Non-current assetsProperty, plant and equipment, net

1,522,920

1,527,430

248,872Goodwill

292,885

292,885

47,721Intangible assets, net

146,512

132,117

21,527Deposits for non-current assets

162,938

70,962

11,562Net investments in direct financing leases, non-current portion

171,545

237,176

38,644Deferred tax assets, non-current portion

18,110

23,580

3,842Equity method investments

230,589

225,785

36,788Other non-current assets

114,758

126,730

20,649Prepaid land lease payments

90,124

88,858

14,478Indemnification as
'/>"/>

SOURCE Concord Medical Services Holdings Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Concord Medical Announces its Successful Closing of the Acquisition of 52% Ownership in Changan Hospital and Provides Guidance for Financial Results of the Second Quarter of 2012
2. CyberKnife System and the da Vinci Surgical System in Concord Medical Centers Achieve Over RMB 10 Million in Medical Revenue Since Opening in February
3. Concord Medicals Changan Hospital and Fox Chase Cancer Center Sign Strategic Alliance Agreement
4. Concordia Study Indicates Obesity is Becoming the Nations Top Health Issue
5. Concord Medical to Report Second Quarter 2012 Financial Results on August 20, 2012
6. Concord Medical Reports Second Quarter 2012 Financial Results
7. Concord Medical Responds to Unusual Market Activity in its Stock
8. Concord Medical to Report Third Quarter 2012 Financial Results on November 21, 2012
9. Concord Medical Announces Change to Third Quarter Financial Results Date to November 20, 2012
10. Concord Medical Reports Third Quarter 2012 Financial Results
11. Concord Medical to Hold Annual General Meeting on December 22, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 2014 Nanomix Inc., (Nanomix), a ... of mobile diagnostic tests to enable earlier ... pre-hospital settings, today announced it has received ... certification was awarded by the British Standards ... certification bodies. ISO 13485:2003 ...
(Date:11/26/2014)... LONDON , Nov. 25, 2014 Amgen ... AZN ) today announced that AMAGINE-2 TM , a pivotal, ... more than 1,800 patients with moderate-to-severe plaque psoriasis, met its ... and placebo at week 12. Brodalumab 210 mg given every ... shown to be superior to Stelara on the primary endpoint ...
(Date:11/26/2014)... SHENZHEN, China, Nov. 26, 2014 China Nepstar ... the "Company"), a leading retail drugstore chain in China ... announced its unaudited financial results for the third quarter ... ended September 30, 2014: , Same store sales increased ... , Revenue increased by 8.1% to RMB738.3 million (US$120.3 ...
Breaking Medicine Technology:Nanomix Receives ISO 13485:2003 Certification 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 11
... 2010 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: ... of medical devices worldwide, today announced its participation in ... Trade Fair with Congress, to be held November 17-20, ... well over 100 countries are expected to attend this ...
... Nov. 11, 2010 Dynatronics Corporation (Nasdaq: DYNT ) ... 2010. Sales for the quarter ended September 30, 2010 ... 2009. Net income for the quarter ended September 30, 2010, was ... share) for the same quarter in the prior fiscal year. ...
Cached Medicine Technology:Mindray Medical to Exhibit at MEDICA 2010 in Dusseldorf, Germany from November 17- 20, 2010 2Mindray Medical to Exhibit at MEDICA 2010 in Dusseldorf, Germany from November 17- 20, 2010 3Dynatronics Announces Fiscal First Quarter Results 2Dynatronics Announces Fiscal First Quarter Results 3
(Date:11/26/2014)... Senior Planning Services, providing “expert guidance for elder ... the adult demographic education and access to computer ... rough seas of applying for Medicaid. Part of this ... of Medicaid eligibility and proper planning, while also helping ... this coverage. , Senior Planning Services has made ...
(Date:11/26/2014)... IL (PRWEB) November 26, 2014 ... communication management solutions, has been award the ... Magazine. , This award comes as a great ... capabilities within the Lync ecosystem. Specifically, ISI offers ... all modes of Lync communication, including voice, video, ...
(Date:11/26/2014)... Albany, NY (PRWEB) November 26, 2014 ... industry research requirements or email the details on sales(at)researchmoz(dot)us ... "Worldwide diabetes and drug discovery market 2014" with deep ... Diabetes is the result of high blood sugar. The ... is directly linked to the growing number of diabetics ...
(Date:11/26/2014)... 2014 Bunion Bootie, the newest and ... an early celebration of the early holiday shopping season. ... at the promotional price of $29.95 each (normally $33.95 ... to any automatic discounts applied when buying more than ... for complete details. It’s simple: purchasing more Bunion ...
(Date:11/26/2014)... 2014 Louisiana Back Institute, leaders ... in minimally invasive spine surgery, announces today the ... rapidly growing provider network of orthopedic spine surgeons ... with the network’s continuing success providing the most ... residents who are suffering from orthopedic spine conditions ...
Breaking Medicine News(10 mins):Health News:Senior Planning Services Teams Up with SeniorNet To Educate Seniors On Medicaid Planning 2Health News:ISI Telemanagement Solutions, Inc. has been Awarded the 2014 Microsoft Lync Pioneer Award 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 3Health News:Bunion Bootie Temporarily Lowering Prices for Holiday Shopping, Starting Today! 2Health News:Louisiana Back Institute Welcomes Dr. K. Samer Shamieh into Medical Provider Network 2
... The most poisonous substance on Earth already used medically ... wrinkles could be re-engineered for an expanded role in ... other diseases, scientists are reporting. Their study appears in ACS, ... that toxins, or poisons, produced by Clostridium botulinum ...
... HealthDay Reporter , TUESDAY, Nov. 29 (HealthDay ... hip replacement devices appear to work the same, a ... seem to be no more effective than older implants ... said. "Metal-on-metal and ceramic-on-ceramic hip implants might not ...
... Findings on coronary CT angiography (CTA), a noninvasive test to ... for men and women, according to a study presented today ... artery disease (CAD) is a narrowing of the blood vessels ... caused by a build-up of fat and other substances that ...
... TUESDAY, Nov. 29 (HealthDay News) -- Men are less willing ... have higher cancer death rates, a new study shows. ... New York City, Baltimore, and San Juan, Puerto Rico, who ... participants were aged 30 to 59, and 35 percent of ...
... Gass, MD, chief of surgery at Women & Infants Hospital ... Health Center in the hospital,s Program in Women,s Oncology, recently ... surgeon Krishna B. Clough, MD, medical director of the Paris ... novel surgical technique available to breast cancer patients through Women ...
... HOUSTON -- Combination treatment with everolimus, an inhibitor ... has shown to improve progression-free survival for patients ... carcinoid syndrome, according to researchers at The University ... of the international, randomized, placebo-controlled Phase III study ...
Cached Medicine News:Health News:New Hip Implants No Better Than Older Ones, Study Finds 2Health News:New Hip Implants No Better Than Older Ones, Study Finds 3Health News:Heart attack risk differs between men and women 2Health News:Men More Likely to Skip Cancer Screenings: Study 2Health News:Surgeon studies with world-renowned oncoplastic pioneer 2Health News:Surgeon studies with world-renowned oncoplastic pioneer 3Health News:Everolimus prolongs progression-free survival for patients with neuroendocrine tumors 2Health News:Everolimus prolongs progression-free survival for patients with neuroendocrine tumors 3
... Pulsavac Wound Debridement System ... for pulsatile irrigation,and debridement. ... range of fluid pressure ... lavage to a penetrating ...
... Amsco 3085 SP Surgical Table provides state-of-the-art ... now be networked with the HERMES Control ... Stryker Endoscopy) to allow the surgeon direct ... surgeon uses either simple voice commands or ...
... The ASC 2000 is ... care table, meeting good manufacturing ... regulatory requirements. It provides electro-hydraulic ... accessories for all ambulatory surgical ...
... The hands play an important part ... traumatic impairments and rheumatic changes can cause ... developing of the finger-joint prostheses was to ... reproduce the natural function as nearly possible.,The ...
Medicine Products: